Jun 13, 2023 07:05AM
Jun 13, 2023 07:00AM
Feb 11, 2021 07:00AM
Dec 29, 2020 07:01AM
Dec 29, 2020 07:00AM
Oct 29, 2020 07:00AM
Oct 12, 2020 07:34AM Alkermes (ALKS) Announces FDA Advisory Committee Votes in Support of ALKS 3831 for the Treatment of Schizophrenia and Bipolar I Disorder (Earlier)
Oct 9, 2020 05:11PM
Oct 9, 2020 07:06AM
Oct 9, 2020 07:05AM
Oct 7, 2020 10:14AM
Oct 7, 2020 10:14AM
Aug 21, 2020 07:01AM
Aug 21, 2020 07:00AM Virtual FDA Advisory Committee Meeting to Review New Drug Application for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder Tentatively Scheduled for Oct. 9, 2020
Aug 17, 2020 07:03AM
Aug 17, 2020 07:00AM
Apr 29, 2020 07:00AM
Mar 4, 2020 07:01AM
Mar 4, 2020 07:00AM
Feb 13, 2020 07:00AM
Jan 28, 2020 09:23AM Pre-Open Stock Movers 1/28: (DLPH) (XLRN) (ALKS) Higher (EROS) (BWA) (DDD) Lower (more...)
Jan 28, 2020 07:01AM
Jan 28, 2020 07:00AM
Jul 30, 2019 07:30AM
Jul 30, 2019 07:30AM
Jul 30, 2019 07:30AM
May 30, 2019 07:36AM
May 30, 2019 07:30AM New Phase 3 Interim Results Support Safety and Efficacy of Diroximel Fumarate in Multiple Sclerosis
May 30, 2019 07:30AM
Feb 25, 2019 07:37AM
Feb 25, 2019 07:30AM
Feb 25, 2019 07:30AM
Feb 25, 2019 07:30AM
Feb 14, 2019 07:00AM
Dec 21, 2018 07:02AM Recro Pharma (REPH) Amends IV Meloxicam License Agreement with Alkermes (ALKS)
Nov 1, 2018 06:24PM
Nov 1, 2018 07:54AM
Nov 1, 2018 07:00AM
Oct 23, 2018 07:00AM
Apr 26, 2018 07:00AM
Feb 14, 2018 07:00AM
Jan 4, 2018 08:17AM Alkermes (ALKS) PT Raised to $56 at Leerink Partners
Nov 16, 2017 07:09AM
Nov 16, 2017 07:00AM
Apr 27, 2017 07:00AM
Mar 20, 2017 07:18AM
Mar 20, 2017 07:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All